| 发明名称 |
Predictors for cancer treatment |
| 摘要 |
The present invention provides methods of predicting a response to a cancer treatment by determining CD68 level or PSMBl (PI 1A) polymorphism in a biological sample and the presence or quantity of a second biomarker in the patient. The invention also provides kits and methods for treating cancer. |
| 申请公布号 |
AU2012294493(B2) |
申请公布日期 |
2017.02.23 |
| 申请号 |
AU20120294493 |
申请日期 |
2012.08.08 |
| 申请人 |
Janssen Pharmaceutica NV |
发明人 |
Ricci, Deborah;Lin, Weimin;Henitz, Erin Devay |
| 分类号 |
G01N33/574 |
主分类号 |
G01N33/574 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
